The FDA has approved EchoPixel’s True3D Viewer which converts anatomical data to 3D virtual reality images.
The FDA has approved EchoPixel’s True3D Viewer, the first platform to convert anatomical data from patients into fully interactive, 3D virtual reality images, EchoPixel announced yesterday.
True3D compiles data from MRI, CT, and all DICOM imaging data to create an interactive holograph of patient-specific body parts, instead of flat 2D images, EchoPixel said in a release. The rendering allows physicians and students to interact with the anatomical structures. True3D’s technology is an effort to dramatically improve speed and efficacy across a broad range of medical operations, the release said.
“Since CT scans were invented in the 1970s, doctors have learned about patient anatomy by mentally piecing together multiple images on flat screens,” Ron Schilling, CEO of EchoPixel, said in the release. “That’s not what the inside of a patient looks like. When working with doctors, we found they were wasting energy trying to solve imaging problems instead of clinical ones. Using virtual reality, we can provide an interactive, three-dimensional view of patient data that is far clearer and more realistic.”
Early clinical trials have shown True3D technology to impact procedures in surgery and radiology, the release said. EchoPixel uses proprietary protocols to formulate and distribute expert-derived methodologies in step-by-step 3D format, according to the release.
[[{"type":"media","view_mode":"media_crop","fid":"33441","attributes":{"alt":"t3D Viewer","class":"media-image","id":"media_crop_6027850334752","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3525","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 209px; width: 400px;","title":"t3D Viewer","typeof":"foaf:Image"}}]]
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.